News & Media

18 November 2024

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the first auth...

4 November 2024

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction to...

30 October 2024

Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP...

9 October 2024

Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is di...

25 September 2024

Every year Stanford University publishes a list of highly cited scientists based on citation metrics from Scopus. The li...

16 September 2024

A breakthrough study, co-led by N2CR member A/Prof Raghav Sundar and includes Prof Jimmy So, A/Prof Yvonne Tay and Dr Yo...

6 September 2024

Multiple myeloma is a cancer of plasma cells, and its development and therapy resistance remain poorly understood. This ...

29 August 2024

This study co-led by N2CR member A/Prof Gautam Sethi, investigates the effects of CHL-C (an imidazopyridine-tethered cha...

22 August 2024

This study explores CD151’s (a protein linked to cancer progression) role in non-small cell lung cancer (NSCLC) pa...